Yoav Lurie
Shaare Zedek Medical Center · 129 works · 6,602 citations · h-index 35
Top works
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- Lamotrigine reduces painful diabetic neuropathy
- Budesonide Induces Remission More Effectively Than Prednisone in a Controlled Trial of Patients With Autoimmune Hepatitis
- A Double-Blind Randomized Placebo-Controlled Trial of Orlistat for the Treatment of Nonalcoholic Fatty Liver Disease
- Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
- International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C
- Randomized Trial of Peginterferon alfa-2b and Ribavirin for 48 or 72 Weeks in Patients with Hepatitis C Virus Genotype 1 and Slow Virologic Response
- The present and future disease burden of hepatitis C virus ( HCV ) infections with today's treatment paradigm – volume 2
- Non-invasive diagnosis of liver fibrosis and cirrhosis
- Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin
- Long-Term Treatment With Entecavir Induces Reversal of Advanced Fibrosis or Cirrhosis in Patients With Chronic Hepatitis B
- Historical epidemiology of hepatitis C virus ( HCV ) in select countries – volume 2
- Dynamic Transperineal Ultrasound in the Diagnosis of Pelvic Floor Disorders
- Extending Combination Therapy With Peginterferon Alfa–2B Plus Ribavirin for Genotype 1 Chronic Hepatitis C Late Responders: A Report of 9 Cases
- Lamivudine treatment for acute severe hepatitis B: a pilot study
- Interferon Alfa-2b in Combination With Ribavirin for the Treatment of Chronic Hepatitis C in Children: Efficacy, Safety, and Pharmacokinetics *
- The Fatty Acid–Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease
- Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine
- Strategies to manage hepatitis C virus ( HCV ) infection disease burden – volume 2
- Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine